|
|
| Line 47: |
Line 47: |
| ! | | ! |
| [[Lipoprotein disorders causes|Causes]] | | [[Lipoprotein disorders causes|Causes]] |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Lipoprotein disorders differential diagnosis|Differentiating Lipoprotein disorders from other Diseases]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Lipoprotein disorders epidemiology and demographics|Epidemiology and Demographics]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Lipoprotein disorders risk factors|Risk Factors]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Lipoprotein disorders screening|Screening]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Lipoprotein disorders natural history, complications and prognosis|Natural History, Complications and Prognosis]]
| |
| |- | | |- |
| ! | | ! |
| Line 83: |
Line 53: |
| ! | | ! |
| Diagnosis | | Diagnosis |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Lipoprotein disorders history and symptoms|History and Symptoms]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Lipoprotein disorders physical examination|Physical Examination]]
| |
| |- | | |- |
| ! | | ! |
| Line 103: |
Line 61: |
| |- | | |- |
| ! | | ! |
|
| |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Lipoprotein disorders other diagnostic studies|Diagnostic Studies]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="CadetBlue"
| |
| !
| |
| Treatment
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders lifestyle modification|Lifestyle Modification]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders medical therapy|Medical Therapy]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders primary prevention| Primary Prevention]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders secondary prevention| Secondary Prevention]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders future or investigational therapies|Future or Investigational Therapies]]
| |
| |-
| |
|
| |
|
| ! | | ! |
| Line 152: |
Line 69: |
| ! | | ! |
|
| |
|
| !
| |
| |- bgcolor="CadetBlue"
| |
| !
| |
| Case Studies
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="PaleTurquoise"
| |
| !
| |
| [[Lipoprotein disorders case study one|Case #1]]
| |
| |-
| |
| ! | | ! |
| |- bgcolor="PaleGoldenrod " | | |- bgcolor="PaleGoldenrod " |